Fig. 2
From: Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc
Dose statistics for the most common OARs in a) oligometastases, b) centrally-located NSCLC and c) LAPC
Advertisement
Fig. 2 | Radiation Oncology
